Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Bruck Claudine Create: Alert

All | News | Filings
Date FiledTypeDescription
01/20/2023 4 Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns: Granted 5,967 options to buy @ $13.17, valued at $78.6k
01/05/2022 4 Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns: Granted 8,000 options to buy @ $19.78, valued at $158.2k
10/13/2021 4 Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns: Bought 181 shares @ $27.66, valued at $5k
07/09/2021 4 Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns: Granted 4,000 options to buy @ $102.85, valued at $411.4k
07/07/2021 4 Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns: Granted 3,969 shares @ $0
01/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2020 4 Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns: Bought 800 shares @ $6, valued at $4.8k
Converted 3,969 shares @ $0
Converted 1,117 shares @ $4.8, valued at $5.4k
Converted 5,556 preferred shares @ $0
Converted 1,117 convertible notes @ $4.8, valued at $5.4k
01/29/2020 3 Bruck Claudine (Director) has filed a Form 3 on Annovis Bio, Inc.
05/15/2019 4 Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns: Bought 2,550 shares @ $1.904, valued at $4.9k
02/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2018 4 Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns: Granted 50,000 shares @ $0.001, valued at $50
Granted 50,000 options @ $0.75, valued at $37.5k
03/14/2018 3 Bruck Claudine (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy